These medications were originally developed to treat type 2 diabetes, and the weight loss effect was discovered as a powerful secondary outcome
The only thing that was disappointing is that medication ingredients supposed to be Tirzepatide 2.5mg w/ Glycine and B12, but I received Tirzaepided 10mg/2ml without Glycine and B12
For example, a 2011 study in rats found that the peptide successfully healed various lesions and promoted healthy weight gain in models of short-bowel syndrome.14 Additionally, as researchers note in the aforementioned 2016 review on BPC-157 and the gut-brain axis, BPC 157 was successful in the therapy of GI tract, periodontitis, liver and pancreas lesions, and in the healing of various tissues and wounds. Its also written in the review that the peptide acts as a mediator of Roberts cytoprotection, defined as the counteraction of the lesions arising from direct detrimental contact with a noxious agent.7 15 Insider Tip: Though there has been some small-scale positive human research on BPC-157, most of the peptides potential uses are based on the outcomes of animal or cell studies
We've seen trends come and go, but the need for reliable, research-grade compounds remains constant